Related references
Note: Only part of the references are listed.Screening study of anti-emetics to improve GDF15-induced malaise and anorexia: Implications for emesis control
Tito Borner et al.
PHYSIOLOGY & BEHAVIOR (2023)
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
Tito Borner et al.
Molecular Metabolism (2023)
Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms
M. Ghidewon et al.
DIABETES OBESITY & METABOLISM (2022)
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models
Tito Borner et al.
DIABETES (2021)
GDF15 Induces Anorexia through Nausea and Emesis
Tito Borner et al.
CELL METABOLISM (2020)
GDF15: A Hormone Conveying Somatic Distress to the Brain
Samuel M. Lockhart et al.
ENDOCRINE REVIEWS (2020)
GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss
Tito Borner et al.
CELL REPORTS (2020)
Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review
Abu Saleh Mohammad Mosa et al.
FRONTIERS IN PHARMACOLOGY (2020)
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
Danna M. Breen et al.
CELL METABOLISM (2020)
Cryo-EM analyses reveal the common mechanism and diversification in the activation of RET by different ligands
Jie Li et al.
eLife (2019)
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Satish Patel et al.
CELL METABOLISM (2019)
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
Henriette Frikke-Schmidt et al.
MOLECULAR METABOLISM (2019)
Chronic nausea and vomiting: evaluation and treatment
Brian E. Lacy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond
Shannon E. Mullican et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
Vicky W. W. Tsai et al.
CELL METABOLISM (2018)
Systematic Comparison of Amber and Rosetta Energy Functions for Protein Structure Evaluation
Aliza B. Rubenstein et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Non - homeostatic body weight regulation through a brainstem-restricted receptor for GDF15
Jer-Yuan Hsu et al.
NATURE (2017)
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Linda Yang et al.
NATURE MEDICINE (2017)
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Shannon E. Mullican et al.
NATURE MEDICINE (2017)
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Paul J. Emmerson et al.
NATURE MEDICINE (2017)
Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
Chen Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers
Emily S. Van Laar et al.
SUPPORTIVE CARE IN CANCER (2015)
Risk factors of chemotherapy-induced nausea and vomiting: Index for personalized antiemetic prophylaxis
Ikuo Sekine et al.
CANCER SCIENCE (2013)
Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy Balance
Harvey J. Grill et al.
CELL METABOLISM (2012)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
TALOS plus : a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts
Yang Shen et al.
JOURNAL OF BIOMOLECULAR NMR (2009)
Drug therapy: Chemotherapy-induced nausea and vomiting
Paul J. Hesketh
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The area postrema: A brain monitor and integrator of systemic autonomic state
Christopher J. Price et al.
NEUROSCIENTIST (2008)
Chemotherapy-induced nausea and vomiting-incidence and impact on patient quality of life at community oncology settings
Lorenzo Cohen et al.
SUPPORTIVE CARE IN CANCER (2007)
Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
Asne R. Bauskin et al.
CANCER RESEARCH (2006)
The Amber biomolecular simulation programs
DA Case et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Incidence of chemotherapy-induced nausea and emesis after modern antiemetics - Perception versus reality
SM Grunberg et al.
CANCER (2004)
Pica in mice as a new model for the study of emesis
K Yamamoto et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2002)
Share Paper
